FDA Releases Guidance on Adverse Event Reporting to Enhance Human Subject Protection

Summary

The Food and Drug Administration (FDA) has published a guidance document to help the research community better report adverse events to protect human subjects, following concerns from the Institutional Review Board (IRB) community about the volume of unanalyzed reports.